Supercharging Co-Development Of Therapeutics & Companion Diagnostics
Welcome to the 13th Annual World Clinical Biomarkers & CDx Summit
The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization, reimbursement and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster.
Whether you are working in Oncology, NASH, or Neuroscience, join 600+ Directors, Heads and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics together with drug and diagnostic developers, regulatory experts, payors and notified bodies for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes.
Snapshot of Our 2023 Expert Speaker Faculty:


Carl Barrett
Vice President - Translational Science & Oncology Institute of Management & Entrepreneurship Development
AstraZeneca




Kristina McGuire
Executive Director & Head of Precision Medicine Laboratory Operations & Companion Diagnostics
Regeneron



Highlights of Last Year's World Clinical Biomarkers & CDx Summit









View the 2023 Event Guide Here

Download your copy to find the 2023 speakers, full agenda breakdown, partners, accessing the best possible rates and to see how biopharma & academia can secure their FREE pass